BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35711892)

  • 1. Discoidin Domain Receptor 2 Expression as Worse Prognostic Marker in Invasive Breast Cancer.
    Romayor I; García-Vaquero ML; Márquez J; Arteta B; Barceló R; Benedicto A
    Breast J; 2022; 2022():5169405. PubMed ID: 35711892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDR2-regulated arginase activity in ovarian cancer-associated fibroblasts promotes collagen production and tumor progression.
    Akinjiyan FA; Ibitoye Z; Zhao P; Shriver LP; Patti GJ; Longmore GD; Fuh KC
    Oncogene; 2024 Jan; 43(3):189-201. PubMed ID: 37996700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth.
    Gonzalez ME; Martin EE; Anwar T; Arellano-Garcia C; Medhora N; Lama A; Chen YC; Tanager KS; Yoon E; Kidwell KM; Ge C; Franceschi RT; Kleer CG
    Cell Rep; 2017 Jan; 18(5):1215-1228. PubMed ID: 28147276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDR2 controls breast tumor stiffness and metastasis by regulating integrin mediated mechanotransduction in CAFs.
    Bayer SV; Grither WR; Brenot A; Hwang PY; Barcus CE; Ernst M; Pence P; Walter C; Pathak A; Longmore GD
    Elife; 2019 May; 8():. PubMed ID: 31144616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Action of Discoidin Domain Receptor 2 in Basal Tumor Cells and Stromal Cancer-Associated Fibroblasts Is Critical for Breast Cancer Metastasis.
    Corsa CA; Brenot A; Grither WR; Van Hove S; Loza AJ; Zhang K; Ponik SM; Liu Y; DeNardo DG; Eliceiri KW; Keely PJ; Longmore GD
    Cell Rep; 2016 Jun; 15(11):2510-23. PubMed ID: 27264173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel insights into the role of Discoidin domain receptor 2 (DDR2) in cancer progression: a new avenue of therapeutic intervention.
    Trono P; Ottavi F; Rosano' L
    Matrix Biol; 2024 Jan; 125():31-39. PubMed ID: 38081526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine kinase-independent actions of DDR2 in tumor cells and cancer-associated fibroblasts influence tumor invasion, migration and metastasis.
    Barcus CE; Hwang PY; Morikis V; Brenot A; Pence P; Clarke M; Longmore GD
    J Cell Sci; 2021 Oct; 134(19):. PubMed ID: 34477203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discoidin domain receptor 2 mediates collagen-induced activation of membrane-type 1 matrix metalloproteinase in human fibroblasts.
    Majkowska I; Shitomi Y; Ito N; Gray NS; Itoh Y
    J Biol Chem; 2017 Apr; 292(16):6633-6643. PubMed ID: 28270508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer.
    Huang T; Lu C; Zhang Y; Lin BY; Zhang ZJ; Zhu D; Wang L; Lu Y
    Ann Med; 2023; 55(2):2250987. PubMed ID: 38375814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins.
    Schab AM; Greenwade MM; Stock E; Lomonosova E; Cho K; Grither WR; Noia H; Wilke D; Mullen MM; Hagemann AR; Hagemann IS; Thaker PH; Kuroki LM; McCourt CK; Khabele D; Powell MA; Mutch DG; Zhao P; Shriver LP; Patti GJ; Longmore GD; Fuh KC
    Mol Cancer Res; 2023 Nov; 21(11):1234-1248. PubMed ID: 37527178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain.
    Grither WR; Longmore GD
    Proc Natl Acad Sci U S A; 2018 Aug; 115(33):E7786-E7794. PubMed ID: 30061414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis.
    Wu C; Ying J; Dai M; Peng J; Zhang D
    J Cancer Res Clin Oncol; 2022 Dec; 148(12):3385-3398. PubMed ID: 35761108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer.
    Toy KA; Valiathan RR; Núñez F; Kidwell KM; Gonzalez ME; Fridman R; Kleer CG
    Breast Cancer Res Treat; 2015 Feb; 150(1):9-18. PubMed ID: 25667101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The collagen structure of C1q induces wound healing by engaging discoidin domain receptor 2.
    Hayuningtyas RA; Han M; Choi S; Kwak MS; Park IH; Lee JH; Choi JE; Kim DK; Son M; Shin JS
    Mol Med; 2021 Oct; 27(1):125. PubMed ID: 34602056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor DDR2.
    Slocum E; Craig A; Villanueva A; Germain D
    Breast Cancer Res; 2019 May; 21(1):56. PubMed ID: 31046834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discoidin domain receptor 2 signaling through PIK3C2α in fibroblasts promotes lung fibrosis.
    Ling S; Kwak D; Takuwa Y; Ge C; Franceschi R; Kim KK
    J Pathol; 2024 Apr; 262(4):505-516. PubMed ID: 38332727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer.
    Kobayashi-Watanabe N; Sato A; Watanabe T; Abe T; Nakashima C; Sueoka E; Kimura S; Sueoka-Aragane N
    Lung Cancer; 2017 Aug; 110():35-41. PubMed ID: 28676216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of discoidin domain receptor 2 (DDR2): a novel independent prognostic marker of worse outcome in breast cancer patients.
    Ren T; Zhang J; Zhang J; Liu X; Yao L
    Med Oncol; 2013 Mar; 30(1):397. PubMed ID: 23307244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia.
    Ren T; Zhang W; Liu X; Zhao H; Zhang J; Zhang J; Li X; Zhang Y; Bu X; Shi M; Yao L; Su J
    J Pathol; 2014 Dec; 234(4):526-37. PubMed ID: 25130389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
    Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
    Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.